TriSalus Life Sciences (TLSI) Misses Q4 EPS by 21c

TriSalus Life Sciences (NASDAQ: TLSI) reported Q4 EPS of ($0.21). Revenue for the quarter came in at $13.2 million.

For earnings history and earnings-related data on TriSalus Life Sciences (TLSI) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
• Netflix (NFLX) Reiterated at Market Perform by Citizens: 'Remains a Clear Leader'